66
Views
38
CrossRef citations to date
0
Altmetric
Original Article

New Insights into the Pathogenesis of Coagulation Dysfunction in Acute Promyelocytic Leukemia

, , &
Pages 27-36 | Received 24 Dec 1992, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Simrit Parmar & Martin S Tallman. (2003) Acute promyelocytic leukaemia:a review. Expert Opinion on Pharmacotherapy 4:8, pages 1379-1392.
Read now
Krzysztof Chojnowski, Ewa Wawfuyniak, Jacek Treilinski, Jolanta Niewiarowska & Czeslaw Cierniewski. (1999) Assessment of Coagulation Disorders in Patients with Acute Leukemia Before and After Cytostatic Treatment. Leukemia & Lymphoma 36:1-2, pages 77-84.
Read now
Wilson H. Miller. (1996) Differentiation Therapy of Acute Promyelocytic Leukemia: Clinical and Molecular Features. Cancer Investigation 14:2, pages 142-150.
Read now

Articles from other publishers (35)

Trevor L. Adams, Gregory J. Latham, Michael J. Eisses, M.A. Bender & Charles M. Haberkern. 2019. A Practice of Anesthesia for Infants and Children. A Practice of Anesthesia for Infants and Children 217 239.e8 .
Robert O Young. (2016) Pathological Blood Coagulation and the Mycotoxic Oxidative Stress Test (MOST). International Journal of Vaccines & Vaccination 2:6.
Crossref
Harry J. Iland, John F. Seymour & Andrew Wei. (2014) Optimal approach for high-risk acute promyelocytic leukemia. Current Opinion in Hematology 21:2, pages 102-113.
Crossref
Xu Chengwei, Ma Xiaoli, Zhang Yuan, Pang Li, Wang Shengjiang, Yu Chao & Wang Yunshan. (2013) Plasma thrombin-activatable fibrinolysis inhibitor levels and its Thr325Ile polymorphism in breast cancer. Blood Coagulation & Fibrinolysis 24:7, pages 698-703.
Crossref
Luisa Soares-Miranda, Carmen Fiuza-Luces & Alejandro Lucia. 2013. Exercise, Energy Balance, and Cancer. Exercise, Energy Balance, and Cancer 159 179 .
Inna Freikman & Eitan Fibach. (2011) Distribution and shedding of the membrane phosphatidylserine during maturation and aging of erythroid cells. Biochimica et Biophysica Acta (BBA) - Biomembranes 1808:12, pages 2773-2780.
Crossref
Dae-Young Kim, Je-Hwan Lee, Jung-Hee Lee, Sung-Doo Kim, Sung-Nam Lim, Yunsuk Choi, Young-Shin Lee, Young-Ah Kang, Miee Seol, Mijin Jeon, Joo Youn Kim, Kyung-Hwa Lee, Yeon-Joo Lee & Kyoo-Hyung Lee. (2011) Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia. Leukemia Research 35:2, pages 152-158.
Crossref
Myoung-Hyun KimCheol-Soon ChoiJae Wook LeePil-Sang JangNak-Gyun ChungBin ChoDae-Chul JeongHack-Ki Kim. (2010) Outcome of childhood acute promyelocytic leukemia treated using a modified AIDA protocol. The Korean Journal of Hematology 45:4, pages 236.
Crossref
Alejandro F. San Juan, Kathleen Wolin & Alejandro Lucía. 2011. Physical Activity and Cancer. Physical Activity and Cancer 319 347 .
Macit Koldas, Mahmut Gumus, Mesut Seker, Hatice Seval, Hulya Karaoglu, Faysal Dane, Alev Kural, Alper Gumus, Taflan Salepci & Nazim Serdar Turhal. (2008) Thrombin-Activatable Fibrinolysis Inhibitor Levels in Patients with Non–Small-Cell Lung Cancer. Clinical Lung Cancer 9:2, pages 112-115.
Crossref
Enric Grau, José María Tenías, María José Soto, María Reyes Gutierrez, Ramón Lecumberri, José Luís Pérez & Gregorio Tiberio. (2007) D-dimer levels correlate with mortality in patients with acute pulmonary embolism: Findings from the RIETE registry. Critical Care Medicine 35:8, pages 1937-1941.
Crossref
Carolina Arbuthnot & Jonathan T. Wilde. (2006) Haemostatic problems in acute promyelocytic leukaemia. Blood Reviews 20:6, pages 289-297.
Crossref
Paul C Winter. (2006) The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology. Hematological Oncology 24:3, pages 126-133.
Crossref
M.S. Tallman, P. Lefèbvre, R.M. Baine, M. Shoji, I. Cohen, D. Green, H.C. Kwaan, E. Paietta & F.R. Rickles. (2004) Effects of all‐trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia. Journal of Thrombosis and Haemostasis 2:8, pages 1341-1350.
Crossref
Martin S. Tallman. 2004. Hematopathology in Oncology. Hematopathology in Oncology 45 67 .
Graham J. Caine, Paul S. Stonelake, Daniel Rea & Gregory Y. H. Lip. (2003) Coagulopathic complications in breast cancer. Cancer 98:8, pages 1578-1586.
Crossref
Anna Falanga & Frederick R Rickles. (2003) Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia. Best Practice & Research Clinical Haematology 16:3, pages 463-482.
Crossref
G Nicolin. (2002) Emergencies and their management. European Journal of Cancer 38:10, pages 1365-1377.
Crossref
Jun Wang, Ivy Weiss, Kristen Svoboda & Hau C. Kwaan. (2001) Thrombogenic role of cells undergoing apoptosis. British Journal of Haematology 115:2, pages 382-391.
Crossref
Frederick R Rickles & Anna Falanga. (2001) Molecular Basis for the Relationship Between Thrombosis and Cancer. Thrombosis Research 102:6, pages V215-V224.
Crossref
Bayard L. Powell. (2001) Acute progranulocytic leukemia. Current Opinion in Oncology 13:1, pages 8-13.
Crossref
M. ?olovi?P. Milji?N. ?olovi?G. Jankovi?M. Stojkovi?. (2001) Reversible Portal Vein Thrombosis Complicating Induction Therapy of Acute Promyelocytic Leukemia. Thrombosis Research 101:2, pages 101-103.
Crossref
B.A. Lwaleed & A.J. Cooper. (2000) Tissue factor expression and multidrug resistance in cancer: two aspects of a common cellular response to a hostile milieu. Medical Hypotheses 55:6, pages 470-473.
Crossref
Takahiro Nakasaki, Hideo Wada, Yoshitaka Mori, Yoshinaga Okugawa, Rika Watanabe, Masakatsu Nishikawa, Esteban C. Gabazza, Masahiro Masuya, Shinichi Kageyama, Kousuke Kumeda, Hisao Kato & Hiroshi Shiku. (2000) Decreased tissue factor and tissue-plasminogen activator antigen in relapsed acute promyelocytic leukemia. American Journal of Hematology 64:3, pages 145-150.
Crossref
T Tenno, J Botling, F Öberg, S Jossan, K Nilsson & A Siegbahn. (2000) The role of RAR and RXR activation in retinoid-induced tissue factor suppression. Leukemia 14:6, pages 1105-1111.
Crossref
Jochanan E. Naschitz, Daniel Yeshurun & Jack Abrahamson. 2000. Textbook of Angiology. Textbook of Angiology 954 962 .
G.-X. ChengX.-H. ZhuX.-Q. MenL. WangQ.-H. HuangX. L. JinS.-M. XiongJ. ZhuW.-M. GuoJ.-Q. ChenS.-F. XuE. SoL.-C. ChanS. WaxmanA. ZelentG.-Q. ChenS. DongJ.-X. LiuS.-J. Chen. (1999) Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF–RAR α and NPM–RAR α . Proceedings of the National Academy of Sciences 96:11, pages 6318-6323.
Crossref
Stanley R. Frankel & Bayard L. Powell. 1999. Diagnostic and Therapeutic Advances in Hematologic Malignancies. Diagnostic and Therapeutic Advances in Hematologic Malignancies 125 153 .
Tiziano BarbuiGuido FinazziAnna Falanga. (1998) The Impact of All-trans-Retinoic Acid on the Coagulopathy of Acute Promyelocytic Leukemia. Blood 91:9, pages 3093-3102.
Crossref
H. Schmidt & T. Lins. (2014) Gerinnungsstörungen bei soliden Tumoren. Der Urologe B 37:3, pages 221-229.
Crossref
Giulia Taraboletti, Patrizia Borsotti, Renato G.S. Chirivi, Veronica Vergani, Anna Falanga, Tiziano Barbui, Raffaella Giavazzi & Alessandro Rambaldi. (1997) Effect of alltrans-retinoic acid (ATRA) on the adhesive and motility properties of acute promyelocytic leukemia cells. International Journal of Cancer 70:1, pages 72-77.
Crossref
Jochanan E. Naschitz, Daniel Yeshurun, Samuel Eldar & Louise M. Lev. (1996) Diagnosis of cancer-associated vascular disorders. Cancer 77:9, pages 1759-1767.
Crossref
Gregory A. Hair, Stephen Padula, Richard Zeff, Mark Schmeizl, Josephine Contrino, Donald L. Kreutzer, Phillipe de Moerloose, Andrew W. Boyd, Irene Stanley, Anthony W. Burgess & Frederick R. Rickles. (1996) Tissue factor expression in human leukemic cells. Leukemia Research 20:1, pages 1-11.
Crossref
Martin S. Tallman. 1995. Hormones and Cancer. Hormones and Cancer 539 576 .
Hugo Vanden Bossche, Luc Koymans & Henri Moereels. (1995) P450 inhibitors of use in medical treatment: Focus on mechanisms of action. Pharmacology & Therapeutics 67:1, pages 79-100.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.